GlassScriptPhysician profile
Jackson Mccrea Ewart
NPI 1699955005
$594.98
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2021: $203 · 2022: $41.17.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $197.52 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $145.42 | 2019 | |
| Medtronic Vascular, INC. | $139.58 | 2019 | |
| Getinge USA Sales, LLC | $47.41 | 2021-2022 | |
| Philips North America LLC | $17.66 | 2021 | |
| Heron Therapeutics, INC. | $17.55 | 2022 | |
| Misonix INC | $15.97 | 2021 | |
| Boston Scientific Corporation | $13.87 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Ewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.